Continucare to Launch Line of Retail Clinics.

Initial Locations Will Be Hosted in Sedano's Pharmacy Stores in South Florida

Clinics Will Provide Treatment for High Demand Family Health Needs

MIAMI -- Continucare Corporation (AMEX:CNU) today introduced Continucare Valuclinic(TM), its new line of consumer-oriented, retail-based health centers. The first four Continucare Valuclinic(TM) health centers are expected to open during the first quarter of 2007 and will be located within Sedano's Pharmacy stores in South Florida.

Continucare Valuclinic(TM) will offer treatment for common family illnesses such as the flu, bronchitis, strep throat, pink eye, skin infections and seasonal allergies, in a quick, convenient, and patient-friendly health care setting. Continucare Valuclinic will also offer other high demand health care services such as common vaccinations, physical examinations and diagnostic screenings. The clinics will be staffed primarily by certified nurse practitioners and physician assistants and will be open seven days a week with extended hours on weekdays. No appointment will be necessary and fees for services will represent a meaningful discount to care provided in more traditional health care settings.

"We are excited to introduce Continucare Valuclinic. These clinics represent a natural extension of our core competency - delivering patient-focused primary care medical services - and permit us to participate in what we believe will be a rapidly growing new health care delivery model," said Richard C. Pfenniger, Jr., Continucare's Chairman and Chief Executive Officer. "With over 40,000 patients currently under the care of our employed and independent affiliated physicians, Continucare has proven expertise in providing comprehensive primary care. Continucare Valuclinic will extend our reach by addressing significant unmet needs in the health care market by focusing exclusively on providing high quality health care for a limited menu of high demand family-oriented services in a consumer friendly manner. Our services will be affordable, accessible and extremely convenient."

Leo Cuervo, President of Sedano's Pharmacy, said, "We are very pleased to partner with Continucare. Sedano's Pharmacy is devoted to satisfying our customers' health care needs. We believe that Continucare's innovative retail-based Valuclinic(TM) model is a great match with our mission of developing a comprehensive offering of health care services. Continucare Valuclinic will expand the range of services available to our customers from within our pharmacy locations and provide them with a new health-care alternative."

About Sedano's Pharmacy

Sedano's Pharmacy is a regional chain founded in 1976, currently operating 15 pharmacies in Miami-Dade and Broward Counties in South Florida. Over the course of its 30 year history, Sedano's Pharmacy has grown by building a reputation for outstanding customer service and tailoring the OTC product mix to the needs of the communities which they serve. In addition to Sedano's prescription departments, selected locations also operate optical and hearing centers.

About Continucare Corporation

Continucare provides primary care physician services on an outpatient basis through a network of medical facilities and independent physician affiliates (IPAs) in the State of Florida. Continucare has 18 medical offices equipped with state-of-the-practice technology and staffed with experienced physicians and a comprehensive support staff. In addition, Continucare provides health practice management services to IPAs who practice primary care medicine in South Florida. Continucare assists these physicians with medical utilization and pharmacy management and specialist network development, freeing them to devote more time to patient care. Currently, through its network of medical facilities and IPAs, Continucare provides health care services for approximately 42,000 patients. For more information please visit www.continucare.com.

Except for historical matters contained herein, statements made in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors and others are cautioned that forward-looking statements are subject to risks and uncertainties that may affect our business and prospects and cause our actual results to differ materially from those set forth in the forward-looking statements. These factors include, without limitation, the risk that Sedano's Pharmacy may have different or conflicting priorities than Continucare's, which may adversely impact their ability or willingness to assist in the development and commercialization of Continucare Valuclinics(TM) or to continue their development programs; the possibility that our development of Continucare Valuclinics(TM) may not proceed on schedule or as expected, the risk that Continucare Valuclinics(TM) may not be successful, uncertainties relating to market acceptance of the Continucare Valuclinic(TM) model, risks associated with increased competition in the primary-health care services market, pricing and other pressures exerted by managed care organizations, the risk that future legislation, changes in governmental regulations, including possible changes in Medicare or Medicaid programs, could adversely impact Continucare's operations or the expected benefits of the Continucare Valuclinics(TM), and general economic conditions and uncertainties generally associated with the health care business. These and other applicable risks, cautionary statements and factors that could cause actual results to differ from our forward-looking statements are included in our annual report on Form 10-K for the fiscal year ended June 30, 2006 and other filings with the SEC. We undertake no obligation to update or revise these forward-looking statements to reflect events or circumstances after the date hereof except as required by law.